| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
United Therapeutics Corp
United Therapeutics Corp
NASDAQ:UTHR
United Therapeutics Corp
Intangible Assets
United Therapeutics Corp
Intangible Assets Peer Comparison
ABBV
GILD
AMGN
VRTX
REGN
Competitive Intangible Assets Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
United Therapeutics Corp
NASDAQ:UTHR
|
Intangible Assets
$115.4m
|
CAGR 3-Years
90%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
44%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Intangible Assets
$62.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
24%
|
CAGR 10-Years
43%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Intangible Assets
$23.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Intangible Assets
$31.4B
|
CAGR 3-Years
25%
|
CAGR 5-Years
35%
|
CAGR 10-Years
9%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Intangible Assets
$834.9m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Intangible Assets
$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is United Therapeutics Corp's Intangible Assets?
Intangible Assets
115.4m
USD
Based on the financial report for Mar 31, 2024, United Therapeutics Corp's Intangible Assets amounts to 115.4m USD.
What is United Therapeutics Corp's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
44%
Over the last year, the Intangible Assets growth was 159%. The average annual Intangible Assets growth rates for United Therapeutics Corp have been 90% over the past three years , -4% over the past five years , and 44% over the past ten years .
You don't have any saved screeners yet
